Treatment of hepatocellular carcinoma in mice with PE38KDEL type I mutant-loaded poly(lactic-co-glycolic acid) nanoparticles conjugated with humanized SM5-1 F(ab') fragments. [electronic resource]
Producer: 20081112Description: 3399-407 p. digitalISSN:- 1535-7163
- Animals
- Antibodies
- Antibodies, Monoclonal -- therapeutic use
- Binding, Competitive -- drug effects
- Carcinoma, Hepatocellular -- drug therapy
- Cell Proliferation -- drug effects
- Endocytosis -- drug effects
- Humans
- Immunoglobulin Fab Fragments -- therapeutic use
- Immunotoxins -- therapeutic use
- Lactic Acid -- metabolism
- Liver Neoplasms -- drug therapy
- Mice
- Microscopy, Confocal
- Nanoparticles
- Polyglycolic Acid -- metabolism
- Polylactic Acid-Polyglycolic Acid Copolymer
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.